SAN DIEGO--(BUSINESS WIRE)--Onchilles Pharma, a private biotech company pioneering pan-cancer therapeutics that leverage the ELANE pathway, today announced the presentation of new preclinical data ...
Peer-reviewed study in Cell Reports Medicine demonstrates that N17350 delivers selective, immune-activating tumor killing across solid tumor types N17350 targets a cancer vulnerability, via the ELANE ...
Shanghai Yidi Biotechnology Co. Ltd. has disclosed neutrophil elastase (ELANE; leukocyte elastase) inhibitors reported to be useful for the treatment of pain and respiratory tract inflammation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results